Reg FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 29, 2022     UNITEDHEALTH GROUP INCORPORATED (Exact name of registrant as specified in its charter)       Delaware   1-10864   41-1321939 (State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   UnitedHealth Group Center , 9900 Bren Road East , Minnetonka , Minnesota   55343 (Address of principal executive offices)   (Zip Code) Registrant’s telephone number, including area code: (952) 936-1300 N/A (Former name or former address, if changed since last report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $.01 par value   UNH   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   ☐ Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐       Item 7.01. Regulation FD Disclosure. On March 29, 2022, UnitedHealth Group Incorporated, a Delaware corporation (“UnitedHealth Group”), and LHC Group, Inc., a Delaware corporation (“LHC”), announced that they have entered into a definitive agreement and plan of merger under which UnitedHealth Group will acquire all outstanding shares of LHC. A copy of UnitedHealth Group’s and LHC’s joint press release is being furnished as Exhibit 99.1 to this Form 8-K. The information in this Item 7.01, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any UnitedHealth Group filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.   Item 9.01. Financial Statements and Exhibits.   Exhibit    Description 99.1    Joint Press Release dated March 29, 2022 104    Cover Page Interactive Data File (formatted as Inline XBRL) Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 29, 2022   UNITEDHEALTH GROUP INCORPORATED By:   /s/ Kuai H. Leong   Kuai H. Leong   Assistant Secretary to the Board of Directors   [ Signature Page to Form 8-K ]